Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Research interviews
-
1. The regulation of cell therapy
- Prof. Moutih Rafei
-
2. How and why neurons die in Alzheimer's disease?
- Prof. Bart De Strooper
-
3. The future of blood tests in cancer treatment
- Dr. Isaac Garcia-Murillas
-
4. Role of marketing authorization holder in drug safety
- Dr. Raphael Elmadjian Pareschi
-
5. Synthetic whole embryo models and their applications
- Prof. Jacob (Yaqub) Hanna
-
6. Scale-up challenges in the production of nanomedicines from lab to industry
- Prof. Dr. Oya Tagit
-
7. Artificial intelligence in precision medicine
- Dr. Michael P. Menden
-
8. Translational medicine: the risk of failure in delay and how to reduce it
- Prof. Martin Wehling
-
9. Challenges and solutions of scaling up
- Dr. Shaukat Ali
-
11. Management of generic drug development: challenges and opportunities
- Mr. Sandeep Patil
-
12. MassBank development and future
- Dr. Emma L. Schymanski
-
13. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
-
14. Translational research in amyotrophic lateral sclerosis (ALS)
- Prof. Aaron D. Gitler
-
16. PANDAS: a potential link between group A streptococcal infections and neurological disorders
- Prof. P. Patrick Cleary
-
17. Rheumatic diseases and musculoskeletal pain
- Prof. Anisur Rahman
-
18. Towards developing a universal influenza vaccine
- Prof. Peter Palese
- Clinical interviews
-
19. Monkeypox: etiopathogenesis, prevention, and treatments
- Dr. Dennis Hruby
-
20. Kidney xenotransplantation
- Dr. Douglas J. Anderson
-
21. CAR-T and TCR-T cellular immunotherapies in oncology
- Prof. Sebastian Kobold
-
22. MAPS: the business of medical affairs
- Dr. Danie du Plessis
-
23. Hypertrophic cardiomyopathy: therapies and treatments
- Prof. Srihari Naidu
-
24. Combating the HIV epidemic
- Prof. William Blattner
-
25. Epigenetic pharmaceuticals used in the clinic
- Dr. Thomas Paul
-
26. Precision cancer medicine: development and future
- Prof. Maurie Markman
-
27. Pediatric cancer testing
- Prof. Joshua Schiffman
-
28. Opposition to vaccination: a transatlantic discussion
- Prof. Jonathan Temte
-
29. Elective caesarean sections from an evolutionary perspective
- Prof. Wenda Trevathan
-
30. Antiphospholipid syndrome and Lupus
- Prof. Graham Hughes
-
31. Prescribing medications to children - a GP’s view
- Dr. Amanda Simmons
Topics Covered
- The global picture of excess and insufficient caesarean sections performed
- Caesarean sections in the context of evolutionary obstetrics
- What are the potential downsides of a caesarean section?
- The influence of caesarean sections on the baby’s acquired microbiome
- The role of the mother, the clinician and the society in the decision making of opting for caesarean sections
- Why do mothers and obstetricians choose caesarean sections even when not necessary?
Biography
Wenda Trevathan is Regents Professor of Anthropology Emerita at New Mexico State University. She is a biological anthropologist whose research focuses on the evolutionary and biocultural factors underlying human reproduction including childbirth, maternal behavior, sexuality and menopause. Her primary publications include works on the evolution of childbirth and evolutionary medicine.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Trevathan, W. (2018, May 30). Elective caesarean sections from an evolutionary perspective [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/YGSC1799.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Wenda Trevathan has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Reproduction & Development
Transcript
Please wait while the transcript is being prepared...
0:00
Interviewer: Professor Trevathan, thank you very much for sparing the time today.
We're discussing elective caesarean sections.
Let me see if I've got your opinion correct.
Is it correct that you accept that there are many medical conditions,
both for the purposes of the health of the baby and the mother,
to support using C-sections,
but you also believe that there are
potentially adverse outcomes from the elective C-sections,
and that your opinion is based upon a consideration of evolutionary perspectives.
Have I got it right?
Prof. Trevathan: That's an excellent summary of my perspective.
Interviewer: Great. We'll come to your opinions on the elective sections shortly.
But, you believe that in many countries,
there are women who should have caesareans,
but are not getting them,
is that also correct?
Prof. Trevathan: That is correct.
Interviewer: Right. So, before we get onto that subject,
which we'll take first,
can we just get a particular term out of the way,
the word natural, the way people often use the word natural.
Given that even before homo sapiens came into existence,
humans have been using their cognitive abilities to adapt to the environment.
Is it very useful to use the word natural?
Prof. Trevathan: I think there's so much confusion about what that means,
that it probably is not a very good term to use anymore.
To some people, it simply means no drugs,
to others it means no intervention.
There even those that think that
the only natural way to give birth is to give birth completely alone,
which is not what I think is characteristic of the human species.